A syringe for injecting contrast injection media into a patient. An inlet valve system associated with the syringe, the inlet valve system operable with a contrast injection media having any viscosity within the range of about 1 cP to about 30 cP. An inlet valve system associated with the syringe, the inlet valve system including a valve member having a density of less than or equal to 1 gram per cubic centimeter. A contrast injector system with such a syringe.

A syringe assembly includes a syringe having a body with a proximal end and a distal end and a discharge outlet formed at the distal end of the syringe. The syringe assembly further includes a closure element having a body configured for removable engagement with at least a portion of the discharge outlet. The body of the closure element is porous to define a tortuous internal path through the body to allow venting of excess pressure within the syringe while preventing pathogens from entering the syringe. The discharge outlet is configured as a luer connector and the closure element has at least one engagement feature for engaging the luer connector.

A syringe including a hollow cylindrical body containing a product to be injected and from which there extend a hollow tip equipped with a Luer-lock connector and a plunger, sliding inside the hollow cylindrical body; and a tamper-proof cap including a closure cap and a tamper-proof insert, where the closure cap includes a portion for coupling with the Luer-lock connector and a handle portion. An external seat for housing the tamper-proof insert is formed in the handle portion of the main body of the closure cap. The tamper-proof insert includes at least one longitudinal section, a transverse section and a terminal element, which is connected to a free end of the longitudinal section by a frangible connection, the terminal element configured to be immovably housed in a corresponding groove formed on an external surface of the Luer-lock connector. The tamper-proof insert is immovably coupled to the closure cap.

A syringe assembly including a plunger rod having a first end, a second end, and a rod portion extending therebetween, wherein at least a portion of the rod portion is flexible is disclosed. The flexible portion of the rod portion allows a stopper to be moved between a first position and a second position within a syringe barrel while the overall length of the syringe assembly remains the same throughout the movement between the first position and the second position. In another embodiment, a syringe assembly including a restraining member adapted to communicate with the flexible portion of the rod portion such that movement of the first end of the plunger rod in a first direction actuates movement of the second end of the plunger rod in a second direction different than the first direction is disclosed.

An elastic and sliding valvular joint for pre-filled syringes, which comprises a single chamber with an injectable product or two chambers that contain isolated products to be mixed before the injection is described. The valvular joint acts as a temporary closure, which prevents the internal chamber from communicating with the outside, or between both internal chambers. The joint comprises two discoid cooperative elements arranged on the syringe and with its edge against the internal surface: an elastic discoid plug and a sliding receiving discoid seat. The receiving discoid seat includes a central passage tube facing the hollow cylinder, and the elastic base of the plug fits in a removable manner inside a cylindrical cavity of the opening of the central passage tube of the seat.

Described herein are syringe caps including a plug portion and a protruding member extending from one end of the plug portion. The protruding member can extend a length greater than a depth of an accumulated component in the syringe.

A cap for a syringe with Luer-lock connector comprising: a main body provided with a first handle portion and a second portion having an external threading for coupling with a corresponding internal threading of the Luer-lock connector of the syringe, an axial cavity having an aperture at the second coupling portion being formed in the main body; and a rubber housed in the axial cavity of the main body. The rubber has a surface facing the aperture of the axial cavity and designed to abut against an open free end of a tip of the syringe for air-tightly closing the open free end and raised elements are formed at the external threading of the second coupling portion.

A seal member is for use with a syringe assembly that comprises a syringe comprising a cylinder body configured to be filled with a drug solution. The seal member includes: a tubular main body part including: an aperture part formed in a proximal end of the main body part, and a contact part configured to form a fluid-tight seal with an inner wall of the cylinder body; and a closed end part at a distal end of the main body part, the closed end part sealing the distal end of the main body part. The closed end part comprises a cleavable part connected to the aperture part, the cleavable part being configured to be cleaved to form a liquid transmission aperture connecting with the aperture part upon application of a prescribed pressure to the a drug solution within a drug solution storage space in the cylinder body.

Provided is a fluid wicking tip. The fluid wicking tipi includes a plurality of drip flanges arranged to wick fluid between narrow spaces defined between any two drip flanges. The narrow spaces are dimensioned to facilitate wicking by capillary action. Also provided is a syringe that includes the fluid wicking tip. Also provided is a modular syringe system that includes a syringe and a sleeve configured to be slidably disposed over the syringe.

The present disclosure relates to the field of medical devices generally and specifically, to endoscopic systems and methods for resection of malignant and pre-malignant lesions within the gastrointestinal (GI) tract. In particular, the present disclosure relates to systems and methods for delivering injectable compositions between tissue layers (e.g., between the muscularis and submucosa layers) to elevate and stabilize the lesion for fast and efficient resection.